This pilot study will evaluate the safety and tolerability of the natural health product, fisetin, in older adults with mild cognitive impairment or mild Alzheimer's disease dementia.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
5
Fisetin 20mg/kg/day
Sunnybrook Research Institute
Toronto, Ontario, Canada
Incidence of Treatment-Emergent Adverse Events (Safety and tolerability of fisetin)
Measured using AE reports
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.